Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum (original) (raw)

Characterizing the Effects of Caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata Isolates by Simultaneous Time-Kill and Postantifungal-Effect Experiments

Hartmut Derendorf

Antimicrobial Agents and Chemotherapy, 2006

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

Lajos Forgács

Infection and Drug Resistance

Dose escalation studies with caspofungin against Candida glabrata

Journal of Medical Microbiology, 2015

Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans

William Kirkpatrick

Antimicrobial Agents and Chemotherapy, 2011

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

Eric Dannaoui

Antimicrobial Agents and Chemotherapy, 2013

Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis

Elisabetta Spreghini

Antimicrobial Agents and Chemotherapy, 2006

Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3

Journal of Antimicrobial Chemotherapy, 2008

Acquired resistance to echinocandins in Candida albicans: case report and review

Naji Aoun, Stephane Bretagne

Journal of Antimicrobial Chemotherapy, 2007

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

Lajos Forgács

Microorganisms

Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods

Journal of Antimicrobial Chemotherapy, 2013

In Vitro Activities of Echinocandins against Candida krusei Determined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies

Antimicrobial Agents and Chemotherapy, 2009

Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata

Tahereh Shokohi

Current Medical Mycology

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Lajos Forgács

Journal of Fungi

Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis

Journal of Antimicrobial Chemotherapy, 2008

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

Ronald Jones

Antimicrobial Agents and Chemotherapy, 2003

Sequential Therapy with Caspofungin and Fluconazole for Candida albicans Infection

Elisabetta Spreghini

Antimicrobial Agents and Chemotherapy, 2004

Echinocandin Susceptibility Testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots

David Perlin

Antimicrobial Agents and Chemotherapy, 2011

In Vitro Study of Candida tropicalis Isolates Exhibiting Paradoxical Growth in the Presence of High Concentrations of Caspofungin

Rudolf Gesztelyi

Antimicrobial Agents and Chemotherapy, 2007

In vitro activity of echinocandins against non-Candida albicans: Is echinocandin antifungal activity the same?

Enfermedades Infecciosas y Microbiología Clínica, 2011

Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin

Donna Maccallum

Journal of Medical Microbiology, 2012

Susceptibility to caspofungin of Candida spp. strains isolated in Ceará, Northeastern Brazil

M. Rozelê Fereira Ângelo, Danielle Macedo

Journal De Mycologie Medicale, 2000

Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results

Journal of chemotherapy (Florence, Italy), 2018

Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience

Shashir Wanjare

Journal of clinical and diagnostic research : JCDR, 2016

Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

Sharon Chen

Antimicrobial Agents and Chemotherapy, 2014

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

David Perlin

Journal of Antimicrobial Chemotherapy, 2006

In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis Evaluated by Time-Kill Studies

Antimicrobial Agents and Chemotherapy, 2010

Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans

Mahmoud Ghannoum

Journal of Antimicrobial Chemotherapy, 2003

The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis

Andy Hoepelman

International Journal of Antimicrobial Agents, 2009

Species-Specific and Drug-Specific Differences in Susceptibility of Candida Biofilms to Echinocandins: Characterization of Less Common Bloodstream Isolates

Aristea Velegraki

Antimicrobial Agents and Chemotherapy, 2013